本页面由Tiger Trade Technology Pte. Ltd.提供服务

Regenxbio Inc

9.49
+0.30003.26%
盘后9.670.1800+1.90%19:57 EDT
成交量:45.40万
成交额:431.59万
市值:4.90亿
市盈率:-2.52
高:9.62
开:9.49
低:9.28
收:9.19
52周最高:16.19
52周最低:5.85
股本:5,161.30万
流通股本:4,299.86万
量比:0.79
换手率:1.06%
股息:- -
股息率:- -
每股收益(TTM):-3.7593
每股收益(LYR):-3.7593
净资产收益率:-107.00%
总资产收益率:-21.93%
市净率:4.77
市盈率(LYR):-2.52

数据加载中...

2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/18

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]